SLNSW-Impact on health‐related quality of life deterior...-TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

Full title: Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

Author/creator: Charton, Emilie, Bachet, Jean‐Baptiste, Hammel, Pascal, Desramé, Jérôme, Chibaudel, Benoist, Cohen, Romain, Debourdeau, Philippe, Dauba, Jérome, Lecomte, Thierry, Seitz, Jean‐François, Tournigand, Christophe, Aparicio, Thomas, Guerin‐Meyer, Véronique, Taieb, Julien, Volet, Julien, Louvet, Christophe, Anota, Amélie, Bonnetain, Franck.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

Language: English

Formats: Articles

Publishers: United States: Wiley Subscription Services, Inc

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    Share

    Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

    Full title

    Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

    Author / Creator

    Charton, Emilie ; Bachet, Jean‐Baptiste ; Hammel, Pascal ; Desramé, Jérôme ; Chibaudel, Benoist ; Cohen, Romain ; Debourdeau, Philippe ; Dauba, Jérome ; Lecomte, Thierry ; Seitz, Jean‐François ; Tournigand, Christophe ; Aparicio, Thomas ; Guerin‐Meyer, Véronique ; Taieb, Julien ; Volet, Julien ; Louvet, Christophe ; Anota, Amélie ; Bonnetain, Franck

    Publisher

    United States: Wiley Subscription Services, Inc

    Journal title

    Cancer medicine (Malden, MA), 2019, Vol.8 (11), p.5079-5088

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    5-Fluorouracil Aged Aged, 80 and over Albumins - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Chemotherapy Clinical Cancer Research clinical trial Clinical trials Death Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives deterioration‐free survival Editing Female Fluorouracil - administration & dosage Gemcitabine Humans Kaplan-Meier Estimate Leucovorin Leucovorin - administration & dosage Male Metastases Metastasis metastatic Middle Aged Original Research Paclitaxel Paclitaxel - administration & dosage Pain Pancreatic cancer Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - epidemiology Pancreatic Neoplasms - mortality Patients Population Product development Prognosis Proportional Hazards Models Quality of Life Questionnaires Sensitivity analysis Studies Supervision Survival Treatment Outcome Writing

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea9e9d8aac3c4e91a964a297380cb6f7

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections